General Information of Drug (ID:
DR0209) |
Drug Name |
Bezafibrate
|
Synonyms |
Befizal; Bezafibrat; Bezafibrato; Bezafibrato [INN-Spanish]; Bezafibrato [Spanish]; Bezafibratum; Bezafibratum [INN-Latin]; Bezalip; Bezalip Retard; Bezatol; Bezatol SR (TN); Azufibrat; Difaterol; Sklerofibrat; bezafibrate; durabezur; 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid; 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid; 41859-67-0; BF-759; BM 15.075; BM 15075; BM-15.075; BRN 4267656; C19H20ClNO4; CCRIS 9085; CHEMBL264374; Cedur; EINECS 255-567-9; LO 44; MLS000028533; UNII-Y9449Q51XH
|
Indication |
Myocardial infarction
[ICD11: BA41]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
361.8 |
Topological Polar Surface Area |
75.6 |
Heavy Atom Count |
25 |
Rotatable Bond Count |
7 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
4 |
Cross-matching ID |
- PubChem CID
- 39042
- PubChem SID
-
855877
; 3221863
; 4720908
; 7848429
; 7978783
; 8149814
; 8175852
; 10321679
; 11112764
; 11121379
; 11121859
; 11335267
; 11360506
; 11362448
; 11364337
; 11365010
; 11366899
; 11367572
; 11369461
; 11370167
; 11370168
; 11372718
; 11373173
; 11373808
; 11375734
; 11377623
; 11461478
; 11466406
; 11467526
; 11484560
; 11486192
; 11488738
; 11491315
; 11492140
; 11495257
; 12015374
; 14926008
; 24891983
; 26612282
; 26680411
; 26747025
; 26747026
; 26751545
; 26751546
; 26751547
; 29214784
; 34704995
; 46509188
; 47217032
; 47291353
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D00WCX
- Formula
- C19H20ClNO4
- Canonical SMILES
- CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
- InChI
- 1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)
- InChIKey
- IIBYAHWJQTYFKB-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.